推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

BREAST CANCER RESEARCH

2024年6月最新影响因子数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 最新评论:暂无评论!


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中国科学院分区:   是否OA期刊:   结果排序:

同行评审状态查询 Manuscript Number * Last Name * First Name * 出版社 * 查 询 重 置

按研究方向查看:


BREAST CANCER RESEARCH期刊基本信息Hello,您是该期刊的第33353位访客

基本信息 登录收藏
期刊名字BREAST CANCER RESEARCHBREAST CANCER RESEARCH

BREAST CANCER RES
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
7.3
50人评分
我要评分

声誉
8.3

影响力
6.5

速度
7.0

期刊ISSN1465-5411
微信扫码收藏此期刊
E-ISSN1465-542X
2023-2024最新影响因子
(数据来源于搜索引擎)
6.1 点击查看影响因子趋势图
实时影响因子 截止2024年3月26日:5.99
2023-2024自引率1.60%点击查看自引率趋势图
五年影响因子7.1
h-index 132
CiteScore
2024年最新版
CiteScoreSJRSNIPCiteScore排名
12.002.5781.865
学科分区排名百分位
大类:Medicine
小类:Oncology
Q145 / 404
大类:Medicine
小类:Cancer Research
Q137 / 230

期刊简介
Breast Cancer Research is an international, peer-reviewed online journal, publishing original research, reviews, editorials and reports. Open access research articles of exceptional interest are published in all areas of biology and medicine relevant to breast cancer, including normal mammary gland biology, with special emphasis on the genetic, biochemical, and cellular basis of breast cancer. In addition to basic research, the journal publishes preclinical, translational and clinical studies with a biological basis, including Phase I and Phase II trials.
期刊官方网站http://breast-cancer-research.biomedcentral.com
期刊投稿网址https://www.editorialmanager.com/brcr/
作者指南网址http://breast-cancer-research.biomedcentral.com/submission-guidelines
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足BREAST CANCER RESEARCH的语言要求,还能让BREAST CANCER RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被BREAST CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问Yes
OA期刊相关信息
文章处理费:需要( GBP2890; USD3990; EUR3290; )
文章处理费豁免:查看说明
其他费用:没有
期刊主题关键词:oncology、breast cancer
相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
通讯方式BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL
出版商BioMed Central
涉及的研究方向医学-肿瘤学
出版国家或地区ENGLAND
出版语言English
出版周期Bimonthly
出版年份1999
年文章数 142点击查看年文章数趋势图
Gold OA文章占比99.42%
研究类文章占比:
文章 ÷(文章 + 综述)
94.37%
WOS期刊SCI分区
2023-2024年最新版
WOS分区等级:1区

按学科分区收录子集JIF分区JIF排名JIF百分位
学科:ONCOLOGYSCIEQ149/322
中国科学院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中国科学院SCI期刊分区
2023年12月最新升级版
点击查看中国科学院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区1区1区
ONCOLOGY
肿瘤学
2区2区2区
中国科学院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区1区3区
ONCOLOGY
肿瘤学
3区3区2区
中国科学院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区4区
ONCOLOGY
肿瘤学
1区4区2区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
Directory of Open Access Journals (DOAJ)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1465-5411%5BISSN%5D
平均审稿速度网友分享经验:
12 Weeks
平均录用比例网友分享经验:
容易
版面费/APC文章处理费信息
文章处理费:需要( GBP2890; USD3990; EUR3290; )
文章处理费豁免:查看说明
其他费用:没有
LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦!
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在BREAST CANCER RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 BREAST CANCER RESEARCH期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 BREAST CANCER RESEARCH中国科学院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
BREAST CANCER RESEARCH上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中国科学院分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发文
  • 中国科学院分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
    中国科学院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE626434
    BIOMATERIALS531739
    BIOMEDICINE & PHARMACOTHERAPY492798
    Journal of Materials Chemistry B473752
    Frontiers in Pharmacology472884
    Frontiers in Immunology446117
    JOURNAL OF ETHNOPHARMACOLOGY425362
    COLLOIDS AND SURFACES B-BIOINTERFACES415859
    COMPUTERS IN BIOLOGY AND MEDICINE405767
    Frontiers in Oncology402462
  •  

    BREAST CANCER RESEARCH BREAST CANCER RESEARCH
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Targeting DCLK1 attenuates tumor stemness and evokes antitumor immunity in triple-negative breast cancer by inhibiting IL-6/STAT3 signaling

    Author: Liu, Heshu; Yan, Rui; Xiao, Zeru; Huang, Xuying; Yao, Jiannan; Liu, Jian; An, Guangyu; Ge, Yang
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-023-01642-3
        PubMed      DOI
    2.MTX-PEG-modified CG/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer

    Author: Cao, Zhiwen; Liu, Rui; Li, Yang; Luo, Xinyi; Hua, Zhenglai; Wang, Xiangpeng; Xue, Zeyu; Zhang, Zhengjia; Lu, Cheng; Lu, Aiping; Liu, Yuanyan
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-022-01599-9
        PubMed      DOI
    3.Association between human blood metabolome and the risk of breast cancer

    Author: Wang, Yu; Liu, Fanghua; Sun, Lulu; Jia, Yiming; Yang, Pinni; Guo, Daoxia; Shi, Mengyao; Wang, Aili; Chen, Guo-Chong; Zhang, Yonghong; Zhu, Zhengbao
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-023-01609-4
        PubMed      DOI
    4.METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer

    Author: Ouyang, Dengjie; Hong, Tao; Fu, Mengdie; Li, Yitong; Zeng, Liyun; Chen, Qitong; He, Hongye; Wen, Ying; Cheng, Yan; Zhou, Meirong; Zou, Qiongyan; Yi, Wenjun
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-022-01598-w
        PubMed      DOI
    5.CMTM7 inhibits breast cancer progression by regulating Wnt/beta-catenin signaling

    Author: Chen, Zhao-Hui; Tian, Yao; Zhou, Guang-Lei; Yue, Hao-Ran; Zhou, Xue-Jie; Ma, Hai-Yan; Ge, Jie; Wang, Xin; Cao, Xu-Chen; Yu, Yue
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-023-01620-9
        PubMed      DOI
    6.RET signaling in breast cancer therapeutic resistance and metastasis

    Author: Pecar, Geoffrey; Liu, Simeng; Hooda, Jagmohan; Atkinson, Jennifer M. M.; Oesterreich, Steffi; Lee, Adrian V. V.
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-023-01622-7
        PubMed      DOI
    7.Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low

    Author: Hu, Xi'e; Yang, Ping; Chen, Songhao; Wei, Gang; Yuan, Lijuan; Yang, Zhenyu; Gong, Li; He, Li; Yang, Lin; Peng, Shujia; Dong, Yanming; He, Xianli; Bao, Guoqiang
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-023-01639-y
        PubMed      DOI
    8.PKC-zeta mediated reduction of the extracellular vesicles-associated TGF-beta 1 overcomes radiotherapy resistance in breast cancer

    Author: Zhang, Fayun; Zheng, Zifeng; Wang, Luoyang; Zeng, Wenfeng; Wei, Wenjing; Zhang, Chunling; Zhao, Ziran; Liang, Wei
    Journal: BREAST CANCER RESEARCH. 2023; Vol. 25, Issue 1, pp. -. DOI: 10.1186/s13058-023-01641-4
        PubMed      DOI
    9.Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).

    Author: Lehuédé C1,2, Li X1,3, Dauvillier S1, Vaysse C1,4, Franchet C5, Clement E1, Esteve D1, Longué M6, Chaltiel L6, Le Gonidec S2, Lazar I1, Geneste A7, Dumontet C7, Valet P2, Nieto L1, Fallone F8, Muller C9.
    Journal: Breast Cancer Res. 2019 Jan 17;21(1):7. doi: 10.1186/s13058-018-1088-6.
        PubMed      DOI
    10.Associations between dietary patterns and the risk of breast cancer: a systematic review and meta-analysis of observational studies.

    Author: Xiao Y1, Xia J1, Li L2, Ke Y1, Cheng J1, Xie Y3, Chu W4, Cheung P5, Kim JH6, Colditz GA7, Tamimi RM8,9, Su X10.
    Journal: Breast Cancer Res. 2019 Jan 29;21(1):16. doi: 10.1186/s13058-019-1096-1.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Disease Primers4876.70
    NATURE REVIEWS CANCER396111.90
    NATURE REVIEWS IMMUNOLOGY35193.40
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    NATURE REVIEWS DRUG DISCOVERY289137.40
    LANCET700148.10
    NEW ENGLAND JOURNAL OF MEDICINE933145.40
    BMJ-British Medical Journal019.90
    BMJ-British Medical Journal019.90
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386173.60
    Nature Reviews Clinical Oncology12799.40
    Nature Reviews Materials61119.40
    Nature Reviews Disease Primers4876.70
 
以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共0条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)

    增值电信业务经营许可证:沪B2-20211595    网络文化经营许可证:沪网文[2023]2004-152号

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室